Transcenta Company
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative antibodies to help more patients. HJB and MabSpace Biosciences merged and created Transcenta.
.png)
.png)
.png)
Technology:
Biopharma, Biotechnology
Industry:
Preclinical Development, Clinical Development
Headquarters:
Huangpu, Shanghai, China
Founded Date:
2019-01-01
Employees Number:
251-500
Funding Status:
Early Stage Venture
Acquisitions Number:
2
Investors Number:
13
Total Funding:
100000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-01-08
Last Funding Type:
Series B
Register and Claim Ownership